Retinal Degeneration  >>  Tookad (padeliporfin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tookad (padeliporfin) / ImPact Biotech
NCT01021956 / 2009-017435-18: Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD

Terminated
2a
10
US, Europe
STAKEL, WST11
Steba Biotech S.A.
Macular Degeneration, Choroidal Neovascularization
05/12
01/14

Download Options